We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AUQ
1151
DELISTED
AURICO GOLD INC COM
AUQ
| $951K | ﹤0.01% |
223,250
| – | – |
2013 Q2
4 quarters
|
|
1152
DELISTED
Amicus Therapeutics
FOLD
| $948K | ﹤0.01% |
283,700
-30,000
| -10% | -$70.4K |
2013 Q2
4 quarters
|
|
1153
Astronics
ATRO
$2.67B
| $935K | ﹤0.01% |
36,276
| – | – |
2013 Q2
4 quarters
|
|
1154
Fortress Biotech
FBIO
$63.4M
| $912K | ﹤0.01% |
35,333
| – | – |
2013 Q4
2 quarters
|
|
1155
Tandy Leather Factory
TLF
$19.5M
| $910K | ﹤0.01% |
100,000
| – | – |
2013 Q3
3 quarters
|
|
1156
Vicor
VICR
$11.3B
| $905K | ﹤0.01% |
108,000
| – | – |
2013 Q2
4 quarters
|
|
|
GHDX
1157
DELISTED
Genomic Health, Inc.
GHDX
| $904K | ﹤0.01% |
33,000
| – | – |
2013 Q2
4 quarters
|
|
1158
Churchill Downs
CHDN
$5.58B
| $901K | ﹤0.01% |
60,000
-771,000
| -93% | -$11.2M |
2013 Q2
4 quarters
|
|
|
AFSI
1159
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $884K | ﹤0.01% |
42,276
+2,200
| +5% | +$45.1K |
2013 Q2
4 quarters
|
|
|
UNTD
1160
DELISTED
UNITED ONLINE INC COM NEW
UNTD
| $882K | ﹤0.01% |
84,828
-8,218
| -9% | -$89.1K |
2013 Q2
4 quarters
|
|
1161
Douglas Dynamics
PLOW
$920M
| $881K | ﹤0.01% |
50,000
| – | – |
2013 Q2
4 quarters
|
|
1162
Myers Industries
MYE
$1.13B
| $862K | ﹤0.01% |
42,900
-16,100
| -27% | -$336K |
2013 Q2
4 quarters
|
|
1163
Regional Management Corp
RM
$308M
| $860K | ﹤0.01% |
55,600
+4,200
| +8% | +$72.1K |
2013 Q2
4 quarters
|
|
1164
InterDigital
IDCC
$8.41B
| $851K | ﹤0.01% |
17,800
+2,100
| +13% | +$81.2K |
2013 Q2
4 quarters
|
|
1165
AAR Corp
AIR
$3.9B
| $843K | ﹤0.01% |
30,600
+3,600
| +13% | +$93.3K |
2013 Q3
3 quarters
|
|
1166
HCI Group
HCI
$2.44B
| $824K | ﹤0.01% |
20,300
+6,500
| +47% | +$252K |
2013 Q3
3 quarters
|
|
1167
Distribution Solutions Group
DSGR
$1.62B
| $819K | ﹤0.01% |
100,538
| – | – |
2013 Q2
4 quarters
|
|
1168
Pultegroup
PHM
$20.8B
| $818K | ﹤0.01% |
40,600
+32,600
| +408% | +$626K |
2013 Q4
2 quarters
|
|
1169
Transact Technologies
TACT
$47M
| $814K | ﹤0.01% |
78,600
| – | – |
2013 Q2
4 quarters
|
|
|
PACW
1170
DELISTED
PacWest Bancorp
PACW
| $813K | ﹤0.01% |
+18,842
| New | +$785K |
2014 Q2
0 quarters
|
|
1171
Imunon
IMNN
$5.84M
| $809K | ﹤0.01% |
85
| – | – |
2013 Q2
4 quarters
|
|
|
AFFX
1172
DELISTED
Affymetrix Inc
AFFX
| $802K | ﹤0.01% |
90,000
| – | – |
2013 Q2
4 quarters
|
|
|
AIMC
1173
DELISTED
Altra Industrial Motion Corp
AIMC
| $793K | ﹤0.01% |
21,800
-7,700
| -26% | -$271K |
2013 Q3
3 quarters
|
|
1174
Rigel Pharmaceuticals
RIGL
$875M
| $782K | ﹤0.01% |
21,539
-9,400
| -30% | -$320K |
2013 Q2
4 quarters
|
|
1175
Polaris
PII
$2.88B
| $768K | ﹤0.01% |
5,900
-3,200
| -35% | -$424K |
2013 Q2
4 quarters
|
|
Similar funds
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.